Anticancer Drug Conjugates Incorporating Estrogen Receptor Ligands

Hormone-dependent cancers, such as certain types of breast cancer are characterized by over-expression of estrogen receptors (ERs). Anticancer drug conjugates combining ER ligands with other classes of anticancer agents may not only benefit from dual action at both anti-cancer targets but also from...

Descripción completa

Detalles Bibliográficos
Autores principales: Zlotos, Darius P., Kronenberger, Thales, Laufer, Stefan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866829/
https://www.ncbi.nlm.nih.gov/pubmed/36678697
http://dx.doi.org/10.3390/pharmaceutics15010067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866829/
https://www.ncbi.nlm.nih.gov/pubmed/36678697
http://dx.doi.org/10.3390/pharmaceutics15010067

Ejemplares similares